Below is a selection of the latest articles and press releases covering the Resolution Therapeutics story
Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD
Edinburgh and London, UK, 13 November 2023 - 1-year results of the MATCH Phase 2 trial of macrophage cell therapy in cirrhosis presented at AASLD
Resolution Therapeutics appoints Dr. Amir Hefni as Chief Executive Officer
London, 14 August 2023 - Resolution Therapeutics announces the appointment of Dr. Amir Hefni as Chief Executive Officer
Resolution Therapeutics Strengthens its Executive Team with the Appointment of Simon Ramsden as Chief Financial Officer
London, 10 July 2023 – Resolution Therapeutics announces the appointment of Simon Ramsden as Chief Financial Officer.
Resolution Therapeutics Strengthens its Team with Senior Appointments
London, 26 June 2023 - Resolution Therapeutics announces the appointment of key senior hires in intellectual property, human resources and clinical operations
Resolution Appoints Liver Disease Expert, Dr Clifford A. Brass, as Chief Medical Officer
London, 2 May 2023 – Resolution Therapeutics announces the appointment of Dr. Clifford A. Brass as Chief Medical Officer
Resolution Expands its CMC Capabilities with Key Hires
London, 30 March 2023 - Resolution Therapeutics announces the appointment of key senior CMC hires in regulatory, quality, process development, analytical development and project management.
Resolution Therapeutics Announces the Appointment of Lisa Bright as Chair of its Board of Directors
London, 9 November 2022 - Resolution announced today the appointment of Lisa Bright as Chairman of its Board of Directors
Resolution Therapeutics and CCRM sign collaboration agreement to develop and scale up manufacturing for iPSC-derived macrophage cell therapies
London, UK and Toronto, Canada, 7 November, 2022 – Resolution Therapeutics and CCRM announce the signing of a collaboration in iPSC-derived macrophage cell therapies.
Resolution Therapeutics Appoints Bill Symonds to its Board of Directors
London, 20 April 2021 – Resolution Therapeutics announces the appointment of Bill Symonds as a Non-Executive Director of the Company.